货号:A611342
同义名:
(±)-Blebbistatin
Blebbistatin是一种选择性非肌肉肌球蛋白 II 抑制剂,能够促进角膜内皮细胞定向迁移,加速伤口愈合,且不会干扰有丝分裂或收缩环组装。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | ATPase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (-)-Blebbistatin | 99%+ | ||||||||||||||||||
| PF 03716556 |
++++
H+/K+-ATPase, pIC50: ~6.5 |
99% | |||||||||||||||||
| Esomeprazole sodium | ✔ | 98% | |||||||||||||||||
| BTB06584 | ✔ | 99% | |||||||||||||||||
| Ciclopirox | ✔ | 97% | |||||||||||||||||
| CB-5083 |
++++
p97 AAA ATPase, IC50: 11 nM |
99%+ | |||||||||||||||||
| Ciclopirox olamine | ✔ | 99% | |||||||||||||||||
| Brefeldin A |
+++
ATPase (HCT 116), IC50: 0.2 μM |
99%+ | |||||||||||||||||
| Oligomycin A | ✔ | 99% | |||||||||||||||||
| Sodium orthovanadate |
+++
(Na,K)-ATPase, IC50: 40 nM |
25-28%V | |||||||||||||||||
| Golgicide A | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Blebbistatin, a selective non-muscle myosin II (NMII) inhibitor, enhances directional migration of corneal endothelial cells (CECs), accelerates wound healing, and preserves cell junctional integrity and barrier function. It impedes cell migration [1][2]. |
| 体内研究 | Blebbistatin (0.05 mL, 20 μM; intracameral injection; daily; for 6 days; New Zealand white rabbits) facilitates wound healing in a rabbit corneal endothelial scraping model [1]. |
| 体外研究 | Investigating the therapeutic potential of targeting NMII to boost CEC migration, blebbistatin promotes migration and directional persistence in CECs, thus expediting wound healing in vitro by reducing actin retrograde flow and increasing lamellipodial protrusion persistence [1]. |
| Concentration | Treated Time | Description | References | |
| human iPSC-derived motor neurons | 25 μM | 24 to 72 h | promotes neurite outgrowth and branching | Nat Commun. 2025 Mar 26;16(1):2975 |
| NIH 3T3 cells | 1 μM and 5 μM | 7 h | Evaluating the effect of Blebbistatin on cell migration, results showed cell migration speed decreased from 15.7 μm/h (control) to 8.8 μm/h (1 μM) and 7.5 μm/h (5 μM). | Biosens Bioelectron. 2021 Dec 1;193:113533 |
| U87 glioblastoma cells | 100 µM | 24 h | To assess the effect of myosin II inhibition on protrusion formation in U87 cells. Results showed that blebbistatin treatment increased protrusion length but reduced alignment of protrusions to fibers. | Biomaterials. 2019 Mar;197:101-118 |
| Human foreskin fibroblast (HFF) cells | 100 µM | 24 h | To assess the effect of myosin II inhibition on protrusion formation in HFF cells. Results showed that blebbistatin treatment did not affect protrusion length but reduced alignment of protrusions to fibers. | Biomaterials. 2019 Mar;197:101-118 |
| Dictyostelium myosin II | 100 μM | Inhibits the ATPase activity of Dictyostelium myosin II with an IC50 of 7 μM and 95% inhibition at 100 μM | Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1472-7. | |
| mouse hepatic stellate cells | 12.5, 25, 50 μM | 24 h | To study the effects of blebbistatin on cell migration. Results showed that blebbistatin promoted wound-induced cell migration. | Br J Pharmacol. 2010 Jan 1;159(2):304-15 |
| mouse hepatic stellate cells | 50 μM | 2 h | To study the effects of blebbistatin on intracellular calcium release. Results showed that blebbistatin blocked endothelin-1-induced intracellular calcium release. | Br J Pharmacol. 2010 Jan 1;159(2):304-15 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6J mice | FeCl3-induced carotid artery thrombosis model | Intraperitoneal injection | 1 mg/kg | Single dose, observed for 60 minutes | To investigate the effect and potential mechanism of blebbistatin on FeCl3-induced carotid artery thrombosis. Results showed that blebbistatin significantly reduced carotid artery thrombosis, inhibited NMMHC IIA expression, and impeded TF expression via the GSK3β-NF-κB signalling pathway. | Int J Biol Sci. 2017 May 15;13(5):630-639 |
| Zebrafish | Transgenic Tg(fli:EGFP) zebrafish larvae | Water solution | 100 µM | Single dose, 24 hours duration | To assess the effect of myosin II inhibition on U87 cell alignment to blood vessels in zebrafish brain. Results showed that blebbistatin treatment reduced alignment of U87 cells to blood vessels. | Biomaterials. 2019 Mar;197:101-118 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.42mL 0.68mL 0.34mL |
17.10mL 3.42mL 1.71mL |
34.21mL 6.84mL 3.42mL |
|
| CAS号 | 674289-55-5 |
| 分子式 | C18H16N2O2 |
| 分子量 | 292.33 |
| SMILES Code | O=C1C2(O)C(N(C3=CC=CC=C3)CC2)=NC4=C1C=C(C)C=C4 |
| MDL No. | MFCD04113775 |
| 别名 | (±)-Blebbistatin |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 25 mg/mL(85.52 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1